57513-54-9,MFCD00117242
Catalog No.:AA00IOIM

57513-54-9 | Ethyl 4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxylate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
>95%
1 week  
$299.00   $209.00
- +
5mg
>95%
1 week  
$319.00   $223.00
- +
10mg
>95%
1 week  
$358.00   $250.00
- +
500mg
>95%
1 week  
$702.00   $492.00
- +
1g
>95%
1 week  
$1,189.00   $833.00
- +
5g
>95%
1 week  
$4,113.00   $2,879.00
- +
10g
>95%
1 week  
$7,523.00   $5,266.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00IOIM
Chemical Name:
Ethyl 4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxylate
CAS Number:
57513-54-9
Molecular Formula:
C13H13NO4
Molecular Weight:
247.2466
MDL Number:
MFCD00117242
SMILES:
CCOC(=O)c1c(O)c2ccccc2n(c1=O)C
Properties
Properties
 
Form:
Solid  

Computed Properties
 
Complexity:
402  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
3  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
1.9  

Downstream Synthesis Route
504-29-0    57513-54-9   
4-hydroxy-1-methyl-2-oxo-N-(pyridin-2-yl)-1,2-dihydroquinolin-3-carboxamide 

[1]Ukrainets,I.V.;Taran,S.G.;Evtifeeva,O.A.;Turov,A.V.[ChemistryofHeterocyclicCompounds,1993,vol.29,#8,p.938-940][KhimiyaGeterotsiklicheskikhSoedinenii,1993,#8,p.1101-1104]

[2]CurrentPatentAssignee:KOREARESEARCHINSTITUTEOFCHEMICALTECHNOLOGY-KR2019/67546,2019,ALocationinpatent:Paragraph0376-0378

[1]Ismaili,Lhassane;Refouvelet,Bernard;Robert,JeanFrancois[JournalofHeterocyclicChemistry,1999,vol.36,#3,p.719-722]

[2]Banu,Saleha;Bollu,Rajitha;Bantu,Rajashaker;Nagarapu,Lingaiah;Polepalli,Sowjanya;Jain,Nishant;Vangala,Radhika;Manga,Vijjulatha[EuropeanJournalofMedicinalChemistry,2017,vol.125,p.400-410]

[3]Banu,Saleha;Bollu,Rajitha;Naseema,Mohammad;Gomedhika,P.Mary;Nagarapu,Lingaiah;Sirisha;Kumar,C.Ganesh;Gundasw,ShravanKumar[BioorganicandMedicinalChemistryLetters,2018,vol.28,#7,p.1166-1170]

[4]Banu,Saleha;Bollu,Rajitha;Nagarapu,Lingaiah;Nanubolu,JagadeeshBabu;Yogeswari,Perumal;Sriram,Dharmarajan;Gunda,ShravanKumar;Vardhan,Divyasphoorthi[ChemicalBiologyandDrugDesign,2018,vol.92,#1,p.1315-1323]

[5]Pudlo,Marc;Luzet,Vincent;Ismaili,Lhassane;Tomassoli,Isabelle;Iutzeler,Anne;Refouvelet,Bernard[BioorganicandMedicinalChemistry,2014,vol.22,#8,p.2496-2507]

[6]Collin;Robert;Duflos;Wielgosz;LeBaut;Robin-Dubigeon;Grimaud;Lang;Petit[JournalofPharmacyandPharmacology,2001,vol.53,#3,p.417-423]

[7]Coppola,GaryM.;Damon,RobertE.;Hardtmann,GoetzE.[Synthesis,1981,#5,p.391-392]

[8]CurrentPatentAssignee:OTSUKAHOLDINGSCOLTD-WO2004/74218,2004,A2Locationinpatent:Page93

[9]CurrentPatentAssignee:GOVERNMENTOFSPAIN-EP2769720,2014,A1Locationinpatent:Paragraph0049

[10]CurrentPatentAssignee:GOVERNMENTOFSPAIN-US2015/57311,2015,A1Locationinpatent:Paragraph0134;0135;0136

[11]Locationinpatent:experimentalpartTomassoli,Isabelle;Ismaili,Lhassane;Pudlo,Marc;DeLosRíos,Cristóbal;Soriano,Elena;Colmena,Inés;Gandía,Luis;Rivas,Luis;Samadi,Abdelouahid;Marco-Contelles,José;Refouvelet,Bernard[EuropeanJournalofMedicinalChemistry,2011,vol.46,#1,p.1-10]

[12]Tomassoli,Isabelle;Herlem,Guillaume;Picaud,Fabien;Benchekroun,Mohamed;Bautista-Aguilera,OscarM.;Luzet,Vincent;Jimeno,María-Luisa;Gharbi,Tijani;Refouvelet,Bernard;Ismaili,Lhassane[MonatsheftefurChemie,2016,vol.147,#6,p.1069-1079]

[13]Shi,Jiandong;Xiao,Zili;Ihnat,MichaelA.;Kamat,Chandrashekhar;Pandit,Bulbul;Hu,Zhigen;Li,Pui-Kai[BioorganicandMedicinalChemistryLetters,2003,vol.13,#6,p.1187-1189]

[14]Jönsson,Stig;Andersson,Gunnar;Fex,Tomas;Fristedt,Tomas;Hedlund,Gunnar;Jansson,Karl;Abramo,Lisbeth;Fritzson,Ingela;Pekarski,Olga;Runström,Anna;Sandin,Helena;Thuvesson,Ingela;Björk,Anders[JournalofMedicinalChemistry,2004,vol.47,#8,p.2075-2088]

[15]Xue,Wenjie;Li,Xueyao;Ma,Guixing;Zhang,Hongmin;Chen,Ya;Kirchmair,Johannes;Xia,Jie;Wu,Song[EuropeanJournalofMedicinalChemistry,2020,vol.188]

[1]Reisch,Johannes;Iding,Marlies;Bassewitz,Ingovon[JournalofHeterocyclicChemistry,1993,vol.30,#4,p.977-980]

768-94-5    57513-54-9   
1'-Adamantyl-4-hydroxy-N-methyl-3-chinolin-2(1H)-on-carbonsaeureamid 

[1]Reisch;Iding[Pharmazie,1993,vol.48,#8,p.620-620]

57513-54-9    28144-70-9   
1-methyl-2-oxo-4-hydroxyquinoline-3-carboxylicacid2-carbamylanilide 

[1]Ukrainets,I.V.;Taran,S.G.;Bezuglyi,P.A.;Kovalenko,S.N.;Turov,A.V.;Marusenko,N.A.[ChemistryofHeterocyclicCompounds,1993,vol.29,#9,p.1044-1047][KhimiyaGeterotsiklicheskikhSoedinenii,1993,#9,p.1223-1226]

Literature

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:57513-54-9 Molecular Formula|57513-54-9 MDL|57513-54-9 SMILES|57513-54-9 Ethyl 4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxylate
Catalog No.: AA00IOIM
57513-54-9,MFCD00117242
57513-54-9 | Ethyl 4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxylate
Pack Size: 1mg
Purity: >95%
1 week
$299.00 $209.00
Pack Size: 5mg
Purity: >95%
1 week
$319.00 $223.00
Pack Size: 10mg
Purity: >95%
1 week
$358.00 $250.00
Pack Size: 500mg
Purity: >95%
1 week
$702.00 $492.00
Pack Size: 1g
Purity: >95%
1 week
$1,189.00 $833.00
Pack Size: 5g
Purity: >95%
1 week
$4,113.00 $2,879.00
Pack Size: 10g
Purity: >95%
1 week
$7,523.00 $5,266.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00IOIM
Chemical Name: Ethyl 4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxylate
CAS Number: 57513-54-9
Molecular Formula: C13H13NO4
Molecular Weight: 247.2466
MDL Number: MFCD00117242
SMILES: CCOC(=O)c1c(O)c2ccccc2n(c1=O)C
Properties
Form: Solid  
Complexity: 402  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 18  
Hydrogen Bond Acceptor Count: 4  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 3  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 1.9  
Downstream Synthesis Route
504-29-0    57513-54-9   
4-hydroxy-1-methyl-2-oxo-N-(pyridin-2-yl)-1,2-dihydroquinolin-3-carboxamide 

[1]Ukrainets,I.V.;Taran,S.G.;Evtifeeva,O.A.;Turov,A.V.[ChemistryofHeterocyclicCompounds,1993,vol.29,#8,p.938-940][KhimiyaGeterotsiklicheskikhSoedinenii,1993,#8,p.1101-1104]

[2]CurrentPatentAssignee:KOREARESEARCHINSTITUTEOFCHEMICALTECHNOLOGY-KR2019/67546,2019,ALocationinpatent:Paragraph0376-0378

10328-92-4    105-53-3    57513-54-9 

[1]Ismaili,Lhassane;Refouvelet,Bernard;Robert,JeanFrancois[JournalofHeterocyclicChemistry,1999,vol.36,#3,p.719-722]

[2]Banu,Saleha;Bollu,Rajitha;Bantu,Rajashaker;Nagarapu,Lingaiah;Polepalli,Sowjanya;Jain,Nishant;Vangala,Radhika;Manga,Vijjulatha[EuropeanJournalofMedicinalChemistry,2017,vol.125,p.400-410]

[3]Banu,Saleha;Bollu,Rajitha;Naseema,Mohammad;Gomedhika,P.Mary;Nagarapu,Lingaiah;Sirisha;Kumar,C.Ganesh;Gundasw,ShravanKumar[BioorganicandMedicinalChemistryLetters,2018,vol.28,#7,p.1166-1170]

[4]Banu,Saleha;Bollu,Rajitha;Nagarapu,Lingaiah;Nanubolu,JagadeeshBabu;Yogeswari,Perumal;Sriram,Dharmarajan;Gunda,ShravanKumar;Vardhan,Divyasphoorthi[ChemicalBiologyandDrugDesign,2018,vol.92,#1,p.1315-1323]

[5]Pudlo,Marc;Luzet,Vincent;Ismaili,Lhassane;Tomassoli,Isabelle;Iutzeler,Anne;Refouvelet,Bernard[BioorganicandMedicinalChemistry,2014,vol.22,#8,p.2496-2507]

[6]Collin;Robert;Duflos;Wielgosz;LeBaut;Robin-Dubigeon;Grimaud;Lang;Petit[JournalofPharmacyandPharmacology,2001,vol.53,#3,p.417-423]

[7]Coppola,GaryM.;Damon,RobertE.;Hardtmann,GoetzE.[Synthesis,1981,#5,p.391-392]

[8]CurrentPatentAssignee:OTSUKAHOLDINGSCOLTD-WO2004/74218,2004,A2Locationinpatent:Page93

[9]CurrentPatentAssignee:GOVERNMENTOFSPAIN-EP2769720,2014,A1Locationinpatent:Paragraph0049

[10]CurrentPatentAssignee:GOVERNMENTOFSPAIN-US2015/57311,2015,A1Locationinpatent:Paragraph0134;0135;0136

[11]Locationinpatent:experimentalpartTomassoli,Isabelle;Ismaili,Lhassane;Pudlo,Marc;DeLosRíos,Cristóbal;Soriano,Elena;Colmena,Inés;Gandía,Luis;Rivas,Luis;Samadi,Abdelouahid;Marco-Contelles,José;Refouvelet,Bernard[EuropeanJournalofMedicinalChemistry,2011,vol.46,#1,p.1-10]

[12]Tomassoli,Isabelle;Herlem,Guillaume;Picaud,Fabien;Benchekroun,Mohamed;Bautista-Aguilera,OscarM.;Luzet,Vincent;Jimeno,María-Luisa;Gharbi,Tijani;Refouvelet,Bernard;Ismaili,Lhassane[MonatsheftefurChemie,2016,vol.147,#6,p.1069-1079]

[13]Shi,Jiandong;Xiao,Zili;Ihnat,MichaelA.;Kamat,Chandrashekhar;Pandit,Bulbul;Hu,Zhigen;Li,Pui-Kai[BioorganicandMedicinalChemistryLetters,2003,vol.13,#6,p.1187-1189]

[14]Jönsson,Stig;Andersson,Gunnar;Fex,Tomas;Fristedt,Tomas;Hedlund,Gunnar;Jansson,Karl;Abramo,Lisbeth;Fritzson,Ingela;Pekarski,Olga;Runström,Anna;Sandin,Helena;Thuvesson,Ingela;Björk,Anders[JournalofMedicinalChemistry,2004,vol.47,#8,p.2075-2088]

[15]Xue,Wenjie;Li,Xueyao;Ma,Guixing;Zhang,Hongmin;Chen,Ya;Kirchmair,Johannes;Xia,Jie;Wu,Song[EuropeanJournalofMedicinalChemistry,2020,vol.188]

16526-19-5    57513-54-9    153334-94-2    153334-93-1 

[1]Reisch,Johannes;Iding,Marlies;Bassewitz,Ingovon[JournalofHeterocyclicChemistry,1993,vol.30,#4,p.977-980]

768-94-5    57513-54-9   
1'-Adamantyl-4-hydroxy-N-methyl-3-chinolin-2(1H)-on-carbonsaeureamid 

[1]Reisch;Iding[Pharmazie,1993,vol.48,#8,p.620-620]

57513-54-9    28144-70-9   
1-methyl-2-oxo-4-hydroxyquinoline-3-carboxylicacid2-carbamylanilide 

[1]Ukrainets,I.V.;Taran,S.G.;Bezuglyi,P.A.;Kovalenko,S.N.;Turov,A.V.;Marusenko,N.A.[ChemistryofHeterocyclicCompounds,1993,vol.29,#9,p.1044-1047][KhimiyaGeterotsiklicheskikhSoedinenii,1993,#9,p.1223-1226]

Literature fold

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology20060501

Building Blocks More >
338393-98-9
338393-98-9
(2E)-2-cyano-N-(2-fluoro-4-hydroxyphenyl)-3-(4-methoxyphenyl)prop-2-enamide
AA00IOLE | MFCD00127295
253774-65-1
253774-65-1
4-(1,2,3-thiadiazol-4-yl)phenyl 4-chlorobenzoate
AA00IOOA | MFCD00113292
478042-02-3
478042-02-3
2-[(2-chlorophenyl)sulfanyl]-1-{2,7-dimethylimidazo[1,2-a]pyridin-3-yl}ethan-1-one
AA00IOR3 | MFCD02186773
170939-29-4
170939-29-4
3-(4-chlorobenzoyl)-4-(2,4-dichlorophenyl)-1H-pyrrole
AA00IOTT | MFCD00794032
338417-65-5
338417-65-5
methyl 3-(2-chloro-6-fluorophenyl)-5-[(E)-2-[(4-methylphenyl)amino]ethenyl]-1,2-oxazole-4-carboxylate
AA00IOWI | MFCD00214744
439096-80-7
439096-80-7
3-(naphthalen-1-yl)-3-(1-oxo-2,3-dihydro-1H-isoindol-2-yl)propanoic acid
AA00IOZH | MFCD03012780
439108-19-7
439108-19-7
5-methyl-N-[2-(pyridin-2-yl)ethyl]thieno[2,3-d]pyrimidin-4-amine
AA00IP22 | MFCD00096435
861211-18-9
861211-18-9
2-{2-[2-(methylamino)-1,3-thiazol-4-yl]ethyl}-2,3-dihydro-1H-isoindole-1,3-dione
AA00IP50 | MFCD04124979
338405-47-3
338405-47-3
5-[1-amino-2-(1H-1,2,4-triazol-1-yl)ethylidene]-2,2-dimethyl-1,3-dioxane-4,6-dione
AA00IP8B | MFCD00141609
338407-38-8
338407-38-8
2-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]-2-(1-methyl-1H-pyrrol-2-yl)acetonitrile
AA00IPAI | MFCD00172221
Submit
© 2017 AA BLOCKS, INC. All rights reserved.